TrialNature communications2025

Gut microbiota-derived metabolite isovalerylcarnitine modulates salt sensitivity of blood pressure and incident hypertension: a multicenter dietary salt intervention trial.

Zhennan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.